Noida Firm’s Licence Cancelled By Uttar Pradesh
According to officials, the manufacturing license of Noida-based pharmaceutical company Marion Biotech was canceled by the Uttar Pradesh government on Wednesday.
Marion Biotech’s Dok-1 cough syrup has been implicated in the deaths of 18 children in Uzbekistan. The incident in December last year prompted central and state drug regulators in India to launch an investigation into the matter.
“The company’s license has been suspended since January, after which a detailed investigation has been started. Currently, the company’s license has been canceled by the Uttar Pradesh Drug Control and Licensing and Control Authority. The company can no longer produce syrup,” a government official said.
On March 3, Noida Police arrested three Marion Biotech employees from their office in Area 67 while a tracking notice was issued against two of their directors after the FIR was filed. filed against them all, the official said.
The FIR came into being after an investigation found that Marion Biotech’s drug samples were “adulterated” and “substandard”. According to the FIR, samples were sent to the government’s regional drug testing laboratory in Chandigarh, and 22 of them were found to be “substandard” (adulterated and forged).
FIR has been filed under Section 274 of Indian Penal Code (mixing of drugs), 275 (selling of adulterated drugs), 276 (selling of drugs as a single drug or other medical preparation) as well as under Section 17 (misbranded drugs) and related violations of the Drugs and Cosmetics Act, 1940.
Marion Biotech was placed under investigation last December because Dok-1 cough syrup was suspected to be the cause of the deaths of 18 children while consuming it in Uzbekistan, after which CDSCO conducted an investigation. investigation into this matter.
The company’s manufacturing license was suspended in January after state and central drug regulators inspected the company’s site following the controversy.
On January 12, the World Health Organization (WHO) also issued a ‘health product warning’, referring to two substandard (contaminated) products, identified in Uzbekistan and reported to the country on December 22, 2022.
“The two products are Ambronol syrup and DOK-1 Max syrup. The stated manufacturer of both products is MARION BIOTECH PVT LTD, (Uttar Pradesh, India). So far, the manufacturer has been has not yet assured WHO of the safety and quality of these products,” WHO later stated.
“Laboratory analysis of samples of both products, carried out by national quality control laboratories of the Ministry of Health of the Republic of Uzbekistan, showed that both products contained trace amounts of diethylene glycol and /or ethylene glycol is an unacceptable contaminant,” it noted.
(Except for the title, this story has not been edited by NDTV staff and is published from an aggregated feed.)